Allianz Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
9,600
-3,400
-26% -$301K ﹤0.01% 1712
2025
Q4
$1.14M Sell
13,000
-6,678
-34% -$547K ﹤0.01% 1684
2025
Q3
$1.31M Sell
19,678
-2,622
-12% -$149K ﹤0.01% 1648
2025
Q2
$1.23M Buy
22,300
+15,900
+248% +$763K ﹤0.01% 1620
2025
Q1
$310K Sell
6,400
-4,600
-42% -$193K ﹤0.01% 2031
2024
Q4
$425K Sell
11,000
-8,300
-43% -$362K ﹤0.01% 1912
2024
Q3
$869K Buy
19,300
+8,200
+74% +$331K ﹤0.01% 1673
2024
Q2
$385K Hold
11,100
﹤0.01% 1911
2024
Q1
$321K Buy
+11,100
New +$302K ﹤0.01% 1728
2023
Q2
Sell
-21,500
Closed -$495K 2265
2023
Q1
$495K Hold
21,500
﹤0.01% 1901
2022
Q4
$235K Buy
+21,500
New +$181K ﹤0.01% 1849
2022
Q3
Sell
-164,075
Closed -$1.3M 2080
2022
Q2
$1.3M Buy
164,075
+31,341
+24% +$379K ﹤0.01% 1582
2022
Q1
$3.14M Sell
132,734
-2,059
-2% -$58K ﹤0.01% 1419
2021
Q4
$4.61M Buy
134,793
+85,622
+174% +$2.71M ﹤0.01% 1271
2021
Q3
$871K Sell
49,171
-25,089
-34% -$1.07M ﹤0.01% 2001
2021
Q2
$3.33M Hold
74,260
﹤0.01% 1281
2021
Q1
$1.92M Hold
74,260
﹤0.01% 1416
2020
Q4
$1.5M Hold
74,260
﹤0.01% 1383
2020
Q3
$1.45M Sell
74,260
-1,530
-2% -$28.7K ﹤0.01% 1343
2020
Q2
$1.34M Sell
75,790
-26,308
-26% -$330K ﹤0.01% 1747
2020
Q1
$720K Buy
102,098
+30,097
+42% +$226K ﹤0.01% 1917
2019
Q4
$507K Sell
72,001
-41,275
-36% -$410K ﹤0.01% 2431
2019
Q3
$1.39M Sell
113,276
-10,814
-9% -$136K ﹤0.01% 1991
2019
Q2
$1.5M Buy
124,090
+47,175
+61% +$522K ﹤0.01% 1998
2019
Q1
$967K Buy
+76,915
New +$679K ﹤0.01% 2113

Other funds holding PTGX